GluSense is developing an innovative long-term, injectable continuous glucose sensor for diabetes patients. Glyde CGM is a miniature, long term, implantable continuous glucose monitoring system for both Type 1 and insulin-dependent Type 2 diabetes patients. The system includes a miniature sensor implanted under the skin and an external wearable device. The wearable device reads the glucose signal from the implant and provides basic display and alarms. Data is additionally sent to a smartphone app for additional display and control functions.
Founded in 2007, the company is part of the Rainbow Medical innovation house.
When was GluSense founded?
GluSense was founded in 2007.
Who are GluSense key executives?
GluSense's key executives are Boaz Brill, Uriel Barkai and Itamar Weisman.
Who are GluSense competitors?
Competitors of GluSense include Metronom Health, Agatsa and Propeller Health.
Where is GluSense headquarters?
GluSense headquarters is located at 3 Prof. Haim Pekeris St, Rehovot.
Where are GluSense offices?
GluSense has an office in Rehovot.
How many offices does GluSense have?
GluSense has 1 office.